Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1997 Jan;41(1):35–39. doi: 10.1128/aac.41.1.35

Beta-lactamases and detection of beta-lactam resistance in Enterobacter spp.

J D Pitout 1, E S Moland 1, C C Sanders 1, K S Thomson 1, S R Fitzsimmons 1
PMCID: PMC163656  PMID: 8980751

Abstract

Enterobacter spp. are becoming increasingly frequent nosocomial pathogens, and beta-lactam-resistant strains are on the increase, especially among isolates recovered from intensive care units. Therefore, a study was designed to characterize the beta-lactamases produced by 80 isolates of E. cloacae, E. aerogenes, E. taylorae, E. gergoviae, E. sakazakii, E. asburiae, and E. agglomerans by induction studies, spectrophotometric hydrolysis assays, and isoelectric focusing. The ability of broth microdilution and disk diffusion susceptibility tests to detect resistance to 16 beta-lactam antibiotics among these species was also assessed. All species except E. agglomerans, E. gergoviae, and some isolates of E. sakazakii were found to produce a Bush group 1 cephalosporinase that was expressed inducibly or constitutively at high levels. In addition, some strains also produced a Bush group 2 beta-lactamase. In comparisons of broth microdilution and disk diffusion tests, disk diffusion tests failed to detect resistance in 1 of 25 isolates resistant to aztreonam and 2 of 30 isolates resistant to ceftazidime. These results indicate that species of Enterobacter can possess a variety of beta-lactamases that are responsible for beta-lactam resistance in this genus and that the disk diffusion test may occasionally miss resistance in some strains.

Full Text

The Full Text of this article is available as a PDF (193.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andresen J., Asmar B. I., Dajani A. S. Increasing Enterobacter bacteremia in pediatric patients. Pediatr Infect Dis J. 1994 Sep;13(9):787–792. doi: 10.1097/00006454-199409000-00007. [DOI] [PubMed] [Google Scholar]
  2. Bauernfeind A., Grimm H., Schweighart S. A new plasmidic cefotaximase in a clinical isolate of Escherichia coli. Infection. 1990 Sep-Oct;18(5):294–298. doi: 10.1007/BF01647010. [DOI] [PubMed] [Google Scholar]
  3. Burchard K. W., Barrall D. T., Reed M., Slotman G. J. Enterobacter bacteremia in surgical patients. Surgery. 1986 Nov;100(5):857–862. [PubMed] [Google Scholar]
  4. Burwen D. R., Banerjee S. N., Gaynes R. P. Ceftazidime resistance among selected nosocomial gram-negative bacilli in the United States. National Nosocomial Infections Surveillance System. J Infect Dis. 1994 Dec;170(6):1622–1625. doi: 10.1093/infdis/170.6.1622. [DOI] [PubMed] [Google Scholar]
  5. Bush K., Jacoby G. A., Medeiros A. A. A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother. 1995 Jun;39(6):1211–1233. doi: 10.1128/aac.39.6.1211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chow J. W., Fine M. J., Shlaes D. M., Quinn J. P., Hooper D. C., Johnson M. P., Ramphal R., Wagener M. M., Miyashiro D. K., Yu V. L. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med. 1991 Oct 15;115(8):585–590. doi: 10.7326/0003-4819-115-8-585. [DOI] [PubMed] [Google Scholar]
  7. De Champs C., Sauvant M. P., Chanal C., Sirot D., Gazuy N., Malhuret R., Baguet J. C., Sirot J. Prospective survey of colonization and infection caused by expanded-spectrum-beta-lactamase-producing members of the family Enterobacteriaceae in an intensive care unit. J Clin Microbiol. 1989 Dec;27(12):2887–2890. doi: 10.1128/jcm.27.12.2887-2890.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ehrhardt A. F., Sanders C. C. beta-Lactam resistance amongst Enterobacter species. J Antimicrob Chemother. 1993 Nov;32 (Suppl B):1–11. doi: 10.1093/jac/32.suppl_b.1. [DOI] [PubMed] [Google Scholar]
  9. Farmer J. J., 3rd, Davis B. R., Hickman-Brenner F. W., McWhorter A., Huntley-Carter G. P., Asbury M. A., Riddle C., Wathen-Grady H. G., Elias C., Fanning G. R. Biochemical identification of new species and biogroups of Enterobacteriaceae isolated from clinical specimens. J Clin Microbiol. 1985 Jan;21(1):46–76. doi: 10.1128/jcm.21.1.46-76.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ferguson R., Feeney C., Chirurgi V. A. Enterobacter agglomerans--associated cotton fever. Arch Intern Med. 1993 Oct 25;153(20):2381–2382. [PubMed] [Google Scholar]
  11. Flynn D. M., Weinstein R. A., Nathan C., Gaston M. A., Kabins S. A. Patients' endogenous flora as the source of "nosocomial" Enterobacter in cardiac surgery. J Infect Dis. 1987 Aug;156(2):363–368. doi: 10.1093/infdis/156.2.363. [DOI] [PubMed] [Google Scholar]
  12. Gallagher P. G. Enterobacter bacteremia in pediatric patients. Rev Infect Dis. 1990 Sep-Oct;12(5):808–812. doi: 10.1093/clinids/12.5.808. [DOI] [PubMed] [Google Scholar]
  13. Georghiou P. R., Hamill R. J., Wright C. E., Versalovic J., Koeuth T., Watson D. A., Lupski J. R. Molecular epidemiology of infections due to Enterobacter aerogenes: identification of hospital outbreak-associated strains by molecular techniques. Clin Infect Dis. 1995 Jan;20(1):84–94. doi: 10.1093/clinids/20.1.84. [DOI] [PubMed] [Google Scholar]
  14. Goldstein F. W., Péan Y., Rosato A., Gertner J., Gutmann L. Characterization of ceftriaxone-resistant Enterobacteriaceae: a multicentre study in 26 French hospitals. Vigil'Roc Study Group. J Antimicrob Chemother. 1993 Oct;32(4):595–603. doi: 10.1093/jac/32.4.595. [DOI] [PubMed] [Google Scholar]
  15. Haddy R. I., Cecil M. L., Norris L. L., Markert R. J. Enterobacter bacteremia in the community hospital. J Fam Pract. 1991 Jun;32(6):601–606. [PubMed] [Google Scholar]
  16. Hawkins R. E., Lissner C. R., Sanford J. P. Enterobacter sakazakii bacteremia in an adult. South Med J. 1991 Jun;84(6):793–795. doi: 10.1097/00007611-199106000-00033. [DOI] [PubMed] [Google Scholar]
  17. Hibbert-Rogers L. C., Heritage J., Gascoyne-Binzi D. M., Hawkey P. M., Todd N., Lewis I. J., Bailey C. Molecular epidemiology of ceftazidime resistant Enterobacteriaceae from patients on a paediatric oncology ward. J Antimicrob Chemother. 1995 Jul;36(1):65–82. doi: 10.1093/jac/36.1.65. [DOI] [PubMed] [Google Scholar]
  18. Jarvis W. R., Martone W. J. Predominant pathogens in hospital infections. J Antimicrob Chemother. 1992 Apr;29 (Suppl A):19–24. doi: 10.1093/jac/29.suppl_a.19. [DOI] [PubMed] [Google Scholar]
  19. Kühn I., Tullus K., Burman L. G. The use of the PhP-KE biochemical fingerprinting system in epidemiological studies of faecal Enterobacter cloacae strains from infants in Swedish neonatal wards. Epidemiol Infect. 1991 Oct;107(2):311–319. doi: 10.1017/s0950268800048950. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Landry P., Kamm W., Bille J., Berger J. P. Sensibilités aux antibiotiques des bactéries isolées dans le laboratoire d'un petit hôpital comparées à celles d'un grand hôpital. Rev Med Suisse Romande. 1991 Feb;111(2):151–156. [PubMed] [Google Scholar]
  21. Lindh E., Dornbusch K., Jalakas K., Forsgren A. Antibiotic susceptibility and beta-lactamase production in clinical isolates of Enterobacter spp. APMIS. 1990 May;98(5):462–470. [PubMed] [Google Scholar]
  22. Lindh E., Kjaeldgaard P., Frederiksen W., Ursing J. Phenotypical properties of Enterobacter agglomerans (Pantoea agglomerans) from human, animal and plant sources. APMIS. 1991 Apr;99(4):347–352. doi: 10.1111/j.1699-0463.1991.tb05160.x. [DOI] [PubMed] [Google Scholar]
  23. Mathew A., Harris A. M., Marshall M. J., Ross G. W. The use of analytical isoelectric focusing for detection and identification of beta-lactamases. J Gen Microbiol. 1975 May;88(1):169–178. doi: 10.1099/00221287-88-1-169. [DOI] [PubMed] [Google Scholar]
  24. McConkey S. J., Coleman D. C., Falkiner F. R., McCann S. R., Daly P. A. Enterobacter cloacae in a haematology/oncology ward--first impressions. J Hosp Infect. 1989 Nov;14(4):277–284. doi: 10.1016/0195-6701(89)90067-4. [DOI] [PubMed] [Google Scholar]
  25. Muytjens H. L., van der Ros-van de Repe J. Comparative in vitro susceptibilities of eight Enterobacter species, with special reference to Enterobacter sakazakii. Antimicrob Agents Chemother. 1986 Feb;29(2):367–370. doi: 10.1128/aac.29.2.367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Rice L. B., Willey S. H., Papanicolaou G. A., Medeiros A. A., Eliopoulos G. M., Moellering R. C., Jr, Jacoby G. A. Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility. Antimicrob Agents Chemother. 1990 Nov;34(11):2193–2199. doi: 10.1128/aac.34.11.2193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Sanders C. C., Sanders W. E., Jr, Moland E. S. Characterization of beta-lactamases in situ on polyacrylamide gels. Antimicrob Agents Chemother. 1986 Dec;30(6):951–952. doi: 10.1128/aac.30.6.951. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Schønheyder H. C., Jensen K. T., Frederiksen W. Taxonomic notes: synonymy of Enterobacter cancerogenus (Urosević 1966) Dickey and Zumoff 1988 and Enterobacter taylorae Farmer et al. 1985 and resolution of an ambiguity in the biochemical profile. Int J Syst Bacteriol. 1994 Jul;44(3):586–587. doi: 10.1099/00207713-44-3-586. [DOI] [PubMed] [Google Scholar]
  29. Sirot D. Extended-spectrum plasmid-mediated beta-lactamases. J Antimicrob Chemother. 1995 Jul;36 (Suppl A):19–34. doi: 10.1093/jac/36.suppl_a.19. [DOI] [PubMed] [Google Scholar]
  30. Snydman D. R. Clinical implications of multi-drug resistance in the intensive care unit. Scand J Infect Dis Suppl. 1991;78:54–63. [PubMed] [Google Scholar]
  31. Thomson K. S., Sanders C. C. Detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae: comparison of the double-disk and three-dimensional tests. Antimicrob Agents Chemother. 1992 Sep;36(9):1877–1882. doi: 10.1128/aac.36.9.1877. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Toala P., Lee Y. H., Wilcox C., Finland M. Susceptibility of Enterobacter aerogenes and Enterobacter cloacae to 19 antimicrobial agents in vitro. Am J Med Sci. 1970 Jul;260(1):41–55. [PubMed] [Google Scholar]
  33. Weischer M., Kolmos H. J. Retrospective 6-year study of enterobacter bacteraemia in a Danish university hospital. J Hosp Infect. 1992 Jan;20(1):15–24. doi: 10.1016/0195-6701(92)90057-s. [DOI] [PubMed] [Google Scholar]
  34. Wüst J., Auckenthaler R., Breer C., Frei R., Heinzer I., Kamm W. Die Antibiotika-Empfindlichkeit von gramnegativen Bakterien auf Intensivpflegestationen in der Schweiz. Schweiz Med Wochenschr. 1994 Oct 1;124(39):1695–1700. [PubMed] [Google Scholar]
  35. de Champs C., Sirot D., Chanal C., Poupart M. C., Dumas M. P., Sirot J. Concomitant dissemination of three extended-spectrum beta-lactamases among different Enterobacteriaceae isolated in a French hospital. J Antimicrob Chemother. 1991 Apr;27(4):441–457. doi: 10.1093/jac/27.4.441. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES